Skip to main content
. Author manuscript; available in PMC: 2014 Dec 17.
Published in final edited form as: J Neuroendocrinol. 2013 Dec;25(12):1280–1289. doi: 10.1111/jne.12113

Fig. 4.

Fig. 4

Relative expression of corticotrophin-releasing hormone (CRH) mRNA in the paraventricular nucleus (PVN) (A) and central amygdala (CeA) (B) mRNA of ovariectomised, nulliparous and age-matched, primiparous females administered vehicle (VEH) or propyl-pyrazole triol (PPT). Home cage females were sacrificed 40 min post-injection. Elevated plus maze (EPM) tested females were sacrificed 10 min after being placed on the EPM. *P < 0.05 compared to home cage, primiparous PPT-treated females. N = 5–7 per group.